• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

News

Article

November 27, 2024

COVID-19 Incidence Among Children Not Related to Elementary School Attendance

Author(s):

Luke Halpern, Assistant Editor

Evidence suggests that precautionary measures in elementary schools were able to effectively mitigate large increases in disease transmission.

Among California children eligible for kindergarten, incidence of COVID-19 decreased over time and was generally lower than other published associations between out-of-school child socialization and COVID-19 incidence, according to new research published in the Journal of the American Medical Association.1

pupils running through school corridor

Investigating the true nature of COVID-19 spread in elementary schools are essential for bettering outcomes among children while affording them a proper educational experience. | Image Credit: © LIGHTFIELD STUDIOS | stock.adobe.com

This evidence suggests that, despite schools holding potential for increased disease spread, precautionary measures instituted because of the COVID-19 pandemic were able to successfully mitigate major increases in disease transmission.1

When the pandemic began, the association of school attendance with the transmission of SARS-CoV-2, the virus that causes COVID-19, was one of the biggest questions among health care professionals as it proved the hardest to answer. Studies investigating transmission among school children related to school were limited early in the pandemic due to concurrent disease mitigation policies, while being costly and cumbersome to conduct.1

Methods are desperately needed to quantify the association of school attendance with COVID-19 transmission rates. One strategy, employed by the investigators through a regression discontinuity design, is analyzing the age threshold for school eligibility as a variable for school exposures. According to the investigators, this strategy avoids the need for extensive data collection required by cohort studies.1

In this trial, the investigators utilize regression discontinuity design to estimate the association between school attendance and infectious disease incidence. The investigators assessed this by comparing COVID-19 incidence and hospitalizations among children born after the age threshold for kindergarten eligibility with those born just before. California was chosen as the study setting due to its large public-school enrollment and its status as the most socioeconomically diverse state.1

The investigators identified a total of 688,278 cases of COVID-19 and 1423 hospitalizations among children who turned 5 years within 224 months of September 1 of the school year when their infection occurred.1

Data indicates that reported COVID-19 incidence was higher among children eligible for school attendance during in-person semesters in the study period. School eligibility incidence rate ratio (IRR) during the fall 2021 semester was 1.52 (95% CI, 1.36-1.68), indicating that age-adjusted incidence rates were 51.5% higher among children eligible for elementary school than those who were not.1

IRR for the spring 2022 semester was 1.26 (95% CI, 1.15-1.39) and 1.19 (95% CI, 1.03-1.38) for the fall 2022 semester. Age-adjusted incidence rates were 26.3% and 19.1% higher for the spring 2022 and fall 2022 semesters, respectively. There was a clear jump in transmission in the fall 2021 semester, but the incidence was observed to decline thereafter.1

Notably, there were no discernible increases in reported age-adjusted COVID-19 hospitalization rates among children born before the school attendance age threshold for any period examined. However, the study authors caution that this observation could be due to the rarity of hospitalization for COVID-19 in children.1

It is critical to compare these observations to the effects of other common sources of transmission, including child social gatherings and large gatherings among adults. Whaley et al investigated the association between social gatherings and COVID-19 risk utilizing the marker of household birthdays, finding a 31% increase in COVID-19 incidence after birthdays. Notably, this is comparable to the estimated effect sizes for the 3 in-person semesters in this trial.1,2

Furthermore, Suñer et al conducted a population-based control-matched analysis to discover the association between mass-gathering outdoor events and the incidence of COVID-19. They found that attendees of a large outdoor festival had a higher cumulative COVID-19 incidence post-festival compared with that of control participants. Still, the results from the current trial indicate that the transmission among children in schools was smaller than the transmission associated with large gatherings among adults.3

Some limitations of the trial were acknowledged, including the inability to determine whether higher COVID-19 incidence was due to in-school or out-of-school exposures associated with school attendance, like after school clubs or sports programs. Additionally, the data from the trial may not be generalizable to states aside from California, which had stricter COVID-19 precautionary measures, and for longer than the rest of the country.1

“The novelty of using this approach to answer questions surrounding infectious disease incidence was both a strength of this study and motivator for future research to characterize sources of bias when using the regression discontinuity approach to study infectious disease transmission within schools,” the investigators concluded.1

REFERENCES
1. Lin E, Bilinski A, Collender PA, et al. COVID-19 incidence and age eligibility for elementary school. JAMA Netw Open. 2024;7(11):e2444836. doi:10.1001/jamanetworkopen.2024.44836
2. Whaley CM, Cantor J, Pera M, et al. Assessing the association between social gatherings and COVID-19 risk using birthdays. JAMA Intern Med. 2021;181(8):1090-1099. doi:10.1001/jamainternmed.2021.2915
3. Suñer C, Coma E, Ouchi D, et al. Association between two mass-gathering outdoor events and incidence of SARS-CoV-2 infections during the fifth wave of COVID-19 in north-east Spain: A population-based control-matched analysis. The LancetRegional Health – Europe. 2022;15:100337. doi:10.1016/j.lanepe.2022.100337

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Image credit: Sebastian Kaulitzki | stock.adobe.com
Health and nutrition: the role of glp-1 in diabetes management with apple and syringe - Image credit: Thanayut | stock.adobe.com
Image credit: K KStock | stock.adobe.com
Image credit: komokvm | stock.adobe.com
Vial of Pneumococcal vaccine - Image credit: Bernard Chantal | stock.adobe.com
Vaccine vials used for Respiratory Syncytial Virus (RSV) with a syringe - Image credit:  Peter Hansen | stock.adobe.com
Related Content
Advertisement
raw vegetables with blood glucose meter, syringe, lancet and stethoscope on desk, diabetes healthy diet concept - Image credit: neirfy | stock.adobe.com
June 12th 2025

Study: How Individual Carbohydrate Responses Reveal Metabolic Health and Potential Biomarkers

Kennedy Ferruggia, Assistant Editor
Pharmacy Focus: Navigating Seasonal Allergies
May 28th 2025

Pharmacy Focus: Navigating Seasonal Allergies

Luke Halpern, Assistant Editor Derek Webb, PharmD
Gardasil box next to syringes | Image Credit: © Unshu - stock.adobe.com
June 12th 2025

The Path to Cervical Cancer Eradication: Overcoming Barriers to HPV Vaccination

Alexandra Gerlach, Associate Editor
Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management
May 6th 2025

Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
Pharmacy students -- Image credit: DusanJelicic | stock.adobe.com
June 12th 2025

Addressing Pharmacy Deserts and Expanding the Pharmaceutical Workforce

Gillian McGovern, Associate Editor
Hepatitis C virus model, 3D illustration. A virus consists of a protein coat, capsid, surrounding RNA and outer lipoprotein envelope with two types of glycoprotein spikes, E1 and E - Image credit: Dr_Microbe | stock.adobe.com
June 11th 2025

Glecaprevir/Pibrentasvir Combination Receives FDA Approval Expanded Indication for Acute HCV

Kennedy Ferruggia, Assistant Editor
Related Content
Advertisement
raw vegetables with blood glucose meter, syringe, lancet and stethoscope on desk, diabetes healthy diet concept - Image credit: neirfy | stock.adobe.com
June 12th 2025

Study: How Individual Carbohydrate Responses Reveal Metabolic Health and Potential Biomarkers

Kennedy Ferruggia, Assistant Editor
Pharmacy Focus: Navigating Seasonal Allergies
May 28th 2025

Pharmacy Focus: Navigating Seasonal Allergies

Luke Halpern, Assistant Editor Derek Webb, PharmD
Gardasil box next to syringes | Image Credit: © Unshu - stock.adobe.com
June 12th 2025

The Path to Cervical Cancer Eradication: Overcoming Barriers to HPV Vaccination

Alexandra Gerlach, Associate Editor
Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management
May 6th 2025

Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
Pharmacy students -- Image credit: DusanJelicic | stock.adobe.com
June 12th 2025

Addressing Pharmacy Deserts and Expanding the Pharmaceutical Workforce

Gillian McGovern, Associate Editor
Hepatitis C virus model, 3D illustration. A virus consists of a protein coat, capsid, surrounding RNA and outer lipoprotein envelope with two types of glycoprotein spikes, E1 and E - Image credit: Dr_Microbe | stock.adobe.com
June 11th 2025

Glecaprevir/Pibrentasvir Combination Receives FDA Approval Expanded Indication for Acute HCV

Kennedy Ferruggia, Assistant Editor
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.